Review
Copyright ©2010 Baishideng.
World J Gastroenterol. Aug 21, 2010; 16(31): 3878-3887
Published online Aug 21, 2010. doi: 10.3748/wjg.v16.i31.3878
Table 1 Frequency of hepatitis B surface antigen-positivity in renal transplant recipients
AuthorsHBsAg rate, % (n)Reference yearCountry of origin
Hu et al[10]20.9 (14/67)1994Taiwan (China)
Mathurin et al[3]115.3 (128/834)1999France
Lee et al[4]12.9 (62/477)2001Taiwan (China)
Chan et al[30]13.2 (67/509)2002Hong Kong (China)
Morales et al[8]22.2 (76/3365)2004Spain
Aroldi et al[20]14.2 (77/541)2005Italy
Santos et al[7]33 (37/1224)2009Portugal
Tsai et al[9]9.2 (51/554)2009Taiwan (China)
Table 2 Efficacy summary of antiviral monotherapy in renal transplant recipients with hepatitis B virus infection
Antiviral agentAuthorsReference yearPatientsDuration (mo)Biochemical response1 (%)Virological response2 (%)Resistance (%)
LamivudineRostaing et al[73]1997664/5 (80)6/6 (100)0
Jung et al[74]1998686/6 (100)6/6 (100)0
Fontaine et al[75]20002616NA26/26 (100)8/26 (31)
Lee et al[82]20011312NA10/13 (77)1/4 (25)
Park et al[83]200110358/10 (80)7/10 (70)1/10 (10)
Chan et al[30]2002263214/14 (100)26/26 (100)11/26 (42)
Thabut et al[95]200414658/14 (57)14/14 (100)8/14 (57)
Kamar et al[96]2004183713/18 (72)6/18 (33)12/18 (67)
AdefovirFontaine et al[90]200511 (LAM-R)159/11 (82)1 (9)0
EntecavirKamar et al[92]20088 (ADV-R)16NA5/8 (63)NA